000			04034nam a22003855i 4500
001			100217
003			DE-He213
005			20230110040209.0
007			cr nn 008mamaa
008			171007s2018 gw | s |||| 0|eng d
020			_a9783319474977 _9
024	7		_a10.1007/978-3-319-47497-7 _2doi
040			_aES-MaUEC _bspa
050		4	_aRC568.O45 _bM336 2018 EB
100	1		_aMcAnally, Heath B. _eautor. _4aut _4http://id.loc.gov/vocabulary/relators/aut _0http://id.loc.gov/authorities/names/no2018071041 _0http://viaf.org/viaf/5152820097200681375
245	1	0	_aOpioid Dependence: _bA Clinical and Epidemiologic Approach _cby Heath B. McAnally.
264		1	_aCham _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XV, 301 páginas 22 ilustraciones, 16 ilustraciones a color)
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
505	0		_aAn Epidemiologic Perspective -- Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology -- Understanding the Agent, Part II: Adverse Effects -- Understanding the Agent, Part III: Specific Drugs -- Attenuating the Agent: Reducing Opioid "Virulence" -- Best Practices Education, Part I: Pain Physiology, Psychology, and Alternatives to Opioids -- Best Practices Education, Part II : Evidence for and against Opioid Therapy -- Best Practices Education, Part III: Regulatory and Advisory Issues Related to Opioid Therapy for Pain -- Addressing Host Factors: Overview of Dependence and Addiction -- Opioid Dependence Risk Factors and Risk Assessment -- Addressing Host Factors: Primary, Secondary and Tertiary Prevention of Opioid Dependence -- Conclusion.
520	3		_aThis unique and timely title offers a comprehensive assessment of the previously underappreciated risks and potentially overstated benefits of chronic opioid therapy. It does so by approaching the rampant problem of opioid abuse and addiction - currently labeled an epidemic in the United States -- from a public health/epidemiologic perspective. That is, following a thorough overview in Part 1 that compares (and contrasts) classic infectious disease epidemiology concepts with the epidemic, the book categorizes our current understanding of basic science and best clinical practices in opioid therapy in terms of Agent (opioid), Vector (prescriber) and Host (patient) factors. The majority of the book, which includes a plethora of instructional case studies, is organized according to these three arenas. Opioid Dependence: A Clinical and Epidemiologic Approach is designed to update all clinicians on opioid basic science, current areas of drug improvement research and development, alternatives to opioid therapy, evidence-based indications for opioid therapy, and clinical strategies for preventing and overcoming opioid dependence. Importantly, an overview of clinical practice guidelines from the American Society of Addiction Medicine, with its biopsychosocial-spiritual "multidimensional assessment" focus is provided, along with a discussion of medication-assisted treatment, organized by the three currently FDA-approved pharmacotherapeutics (methadone, buprenorphine and naltrexone). Developed for practitioners at every level, this ground-breaking title offers a fresh and novel approach to improving the care and outcomes of patients receiving opioid therapy.
650		7	_aPsiquiatría _2embne _9139041
650		7	_aNeurología _2embne _9139040
650		7	_aDolor _2embne _9137881
776	0	8	_iEdición impresa: _z9783319474960
776	0	8	_iEdición impresa: _z9783319474984
776	0	8	_iEdición impresa: _z9783319837512
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-47497-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490	0		_aMedicine (Springer-11650)
988			_aSpringer_Medicine_2018
998			_b02/2019 _dz _ep _feng _ggw _h0
999			_c100217 _d100217 _x1